Diaceutics PLC
DIUXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $15 | $20 | $12 | $14 |
| % Growth | -26.6% | 61% | -10.6% | – |
| Cost of Goods Sold | $2 | $2 | $4 | $3 |
| Gross Profit | $12 | $18 | $9 | $11 |
| % Margin | 83% | 88.4% | 69.9% | 79.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $15 | $16 | $0 | $12 |
| SG&A Expenses | $15 | $16 | $12 | $12 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $15 | $16 | $12 | $12 |
| Operating Income | -$3 | $1 | -$4 | -$1 |
| % Margin | -21.8% | 5.7% | -29.2% | -6.2% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$3 | $1 | -$3 | -$0 |
| Tax Expense | $1 | $0 | -$1 | -$0 |
| Net Income | -$2 | $1 | -$3 | -$0 |
| % Margin | -16.5% | 4.4% | -21% | -1.9% |
| EPS | -0.028 | 0.01 | -0.031 | -0.003 |
| % Growth | -373.1% | 134% | -887.1% | – |
| EPS Diluted | -0.057 | 0.01 | -0.031 | -0.003 |
| Weighted Avg Shares Out | 42 | 85 | 84 | 84 |
| Weighted Avg Shares Out Dil | 85 | 84 | 84 | 84 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$1 | $3 | -$1 | $2 |
| % Margin | -9.2% | 13.4% | -7.8% | 11.4% |